Monday, August 20, 2018

KING OF PRUSSIA, Pa., Aug. 17, 2018 /PRNewswire/ -- Recovery Centers of America (RCA), a community-based addiction treatment provider delivering evidence-based care, is proud to have received approval to advertise on Facebook. RCA's recent cer.....   [READ MORE]
FREDERICK, Md., Aug. 17, 2018 /PRNewswire-PRWeb/ -- The Mental Health Association of Frederick County, Maryland (MHA) is pleased to welcome Psychiatrist Lynn Feldman, D.O. to the Counseling Services staff.   [READ MORE]
“Kidney stone extraction balloons Market: Global Demand Analysis & Opportunity Outlook 2027”

The global Kidney ston...
LEAWOOD, Kan. and KANSAS CITY, Mo., Aug. 16, 2018 /PRNewswire/ -- United Medicare Advisors and Social Security Solutions have partnered to help millions of Americans make smarter decisions in retirement as part of a holistic approach to retirement planning. The partnership unites the healthcar.....   [READ MORE]
NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Klara, the secure healthcare communication platform, announced its Series A funding round of $11.5million led by FirstMark Capital, and joined by existing investors such as Lerer Hippeau, Project A Ventures, and Atlantic Labs. Klara also welcomed the support of a few seasoned entreprene.....   [READ MORE]

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines